Related Experiment Video
Updated: Jun 5, 2026

Development of a Negative Selectable Marker for Entamoeba histolytica
Published on: December 12, 2010
Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection
Suresh M Ganesan1, Joanne M Morrisey, Hangjun Ke
1Center for Molecular Parasitology, Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 W. Queen Lane, Philadelphia, PA 19129, USA.
Abstract:
Genetic manipulation of Plasmodium falciparum in culture through transfection has provided numerous insights into the molecular and cell biology of this parasite. The procedure is rather cumbersome, and is limited by the number of drug-resistant markers that can be used for selecting transfected parasites. Here we report a new selectable marker that could allow multiple transfections. We have taken advantage of our finding that a critical function of the mitochondrial electron transport chain (mtETC) in the erythrocytic stages of P. falciparum is the regeneration of ubiquinone as co-substrate of dihydroorotate dehydrogenase (DHODH), and that transgenic P. falciparum expressing ubiquinone-independent DHODH from yeast (yDHODH) are resistant to all mtETC inhibitors. We assessed the possibility of using yDHODH as a positive selectable marker for transfections of P. falciparum, including its use in gene disruption strategies. We constructed a transfection vector designed for gene disruption, termed pUF-1, containing the yDHODH gene as the positive selection marker in combination with a previously described fused yeast cytosine deaminase-uracil phosphoribosyl transferase gene as a negative selection marker. Transfection of the D10 strain followed by selection with atovaquone yielded positively selected parasites containing the plasmid, demonstrating that yDHODH can be used as a selective marker. Atovaquone, however, could not be used for such selection with the Dd2 strain of P. falciparum. On the other hand, we demonstrated that yDHODH transgenic parasites could be selected in both strains by Plasmodium DHODH-specific triazolopyrimidine-based inhibitors. Thus, selection with DHODH inhibitors was superior in that it successfully selected transgenic Dd2 parasites, as well as yielded transgenic parasites after a shorter period of selection. As a proof of concept, we have successfully disrupted the type II vacuolar proton-pumping pyrophosphatase gene (PfVP2) in P. falciparum by double crossover recombination, showing that this gene is not essential for the survival of blood stage parasites.
Insights
Researchers developed a new selectable marker for genetically modifying Plasmodium falciparum, enabling multiple transfections. This yeast-derived ubiquinone-independent dihydroorotate dehydrogenase (yDHODH) allows for efficient gene disruption in malaria parasites.
Area of Science:
- Molecular Biology
- Parasitology
- Genetics
Background:
- Genetic manipulation of Plasmodium falciparum is crucial for understanding its biology but is limited by available selectable markers.
- Existing methods for transfecting malaria parasites are cumbersome and restrict the number of simultaneous genetic modifications possible.
Purpose of the Study:
- To develop and validate a novel selectable marker for Plasmodium falciparum transfections.
- To assess the utility of yeast-derived ubiquinone-independent dihydroorotate dehydrogenase (yDHODH) as a positive selectable marker.
- To demonstrate its application in gene disruption strategies for Plasmodium falciparum.
Main Methods:
- Constructed a transfection vector (pUF-1) incorporating the yDHODH gene for positive selection and a yeast cytosine deaminase-uracil phosphoribosyl transferase gene for negative selection.
- Transfected Plasmodium falciparum strains (D10 and Dd2) and selected for transgenic parasites using various inhibitors.
- Performed gene disruption of the PfVP2 gene via double crossover recombination.
Main Results:
- Successfully used yDHODH as a positive selectable marker in the D10 strain with atovaquone, and in both D10 and Dd2 strains using Plasmodium DHODH-specific triazolopyrimidine-based inhibitors.
- DHODH inhibitors proved superior, enabling selection in the Dd2 strain and reducing selection time.
- Demonstrated proof-of-concept by successfully disrupting the PfVP2 gene, indicating it's non-essential for blood-stage survival.
Conclusions:
- Yeast-derived ubiquinone-independent dihydroorotate dehydrogenase (yDHODH) serves as a versatile and effective positive selectable marker for Plasmodium falciparum transfections.
- DHODH inhibitors offer a robust selection method, particularly for strains like Dd2, and expedite the process.
- This new marker facilitates advanced genetic studies, including gene disruption, advancing our understanding of malaria parasite biology.

